Amphetamine and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Amphetamine (amphetamine), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Xyrem, and have Attention deficit hyperactivity disorder.

The phase IV clinical study analyzes which people have Drowsiness when taking Amphetamine. It is created by eHealthMe based on reports of 972 people who have side effects when taking Amphetamine from the FDA, and is updated regularly.

What is Amphetamine?

Amphetamine has active ingredients of amphetamine. eHealthMe is studying from 980 Amphetamine users. Check the latest studies of Amphetamine.

What is Drowsiness?

Drowsiness is found to be associated with 2,877 drugs and 4,758 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Oct, 06, 2025

972 people reported to have side effects when taking Amphetamine.
Among them, 28 people (2.88%) have Drowsiness.

Among these 28 people:

How long have people been on Amphetamine when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Amphetamine? *

female: 59.26 %
male: 40.74 %

What is the age of people who have Drowsiness when taking Amphetamine? *

What are other drugs people take besides Amphetamine? *

What are other side effects people have besides Drowsiness? *

Fatigue (feeling of tiredness): 10 people, 35.71%
Agitation (state of anxiety or nervous excitement): 7 people, 25.00%
Drug Abuse: 7 people, 25.00%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 7 people, 25.00%
Suicide Attempt: 7 people, 25.00%
Irritability: 6 people, 21.43%
Compartment Syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels): 6 people, 21.43%
Myelopathy (any neurologic deficit related to the spinal cord): 6 people, 21.43%
Loss Of Consciousness: 5 people, 17.86%
Drug Ineffective: 5 people, 17.86%

What are the existing conditions these people have? *

Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 4 people, 14.29%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 10.71%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 10.71%
High Blood Cholesterol: 2 people, 7.14%
Asthma: 2 people, 7.14%
Bipolar Disorder (mood disorder): 2 people, 7.14%
Pain: 2 people, 7.14%
Headache (pain in head): 2 people, 7.14%
Heart Attack: 2 people, 7.14%
Venous Thrombosis (blood clot (thrombus) that forms within a vein): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Amphetamine and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amphetamine:

Amphetamine (980 reports)

Drowsiness treatments and more:

Drowsiness (269,039 reports)

Browse all side effects of Amphetamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,877 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,758 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amphetamine (the active ingredients of Amphetamine) and Amphetamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.